Paragon BioTeck, a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices, and therapies, recently completed the reformulation for the Freshkote family of lubricant eye drops, purchased this week by Eyevance Pharmaceuticals. “We are pleased to be able to have a role in the improvements made to the…